CoChat
Sign Up
Cited by 97

The DOI matches its Crossref record, with a small difference in title or year.

The Inhibitory Role of DOC-2/DAB2 in Growth Factor Receptor-mediated Signal Cascade

Zhou, Jian, Hsieh, Jer-Tsong·2001·Journal of Biological Chemistry
DOI 10.1074/jbc.m102803200
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m102803200

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Endocytosis and trafficking of cell surface receptors and signaling components account for Dab2's activities in modulating Ras/MAPK, TGF-beta, and Wnt pathways.

    “Indeed, endocytosis and trafficking of cell surface receptors and signaling components have been suggested to account for its activities in modulating multiple cellular signaling pathways, including Ras/MAPK”

    From Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice (2016) · cites this paper as Zhou and Hsieh, 2001

    The Abstract and Discussion (pages unavailable) support Dab2’s modulation of the Ras/MAPK pathway through binding Grb2 and interrupting its interaction with SOS. They do not support endocytosis or trafficking as the mechanism, or address Dab2’s modulation of TGF-beta and Wnt pathways. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

  • By competing with Sos1 for binding to Grb2, Dab2 acts as a negative regulator for the Ras/MAPK pathway.

    “By competing with Sos1 for binding to Grb2, Dab2 acts as a negative regulator for Ras/MAPK pathway (Xu et al., 1998; Zhou and Hsieh, 2001).”

    From Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice (2016) · cites this paper as Zhou and Hsieh, 2001

  • Dab2 tumor suppressor function is attributed to suppressing Ras/MAPK signaling.

    “The tumor suppressor functions of Dab2 have been attributed to its roles in suppressing Ras/MAPK signaling (He et al., 2001; Zhou and Hsieh, 2001)”

    From Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice (2016) · cites this paper as Zhou and Hsieh, 2001

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 24

  1. Mok, 1998, Oncogene, 16, 2381, 10.1038/sj.onc.1201769 · DOI · Paper page
  2. Fulop, 1998, Oncogene, 17, 419, 10.1038/sj.onc.1201955 · DOI
  3. Tseng, 1998, Endocrinology, 139, 3542, 10.1210/endo.139.8.6159 · DOI · Paper page
  4. Schwahn, 1998, Oncogene, 17, 1171, 10.1038/sj.onc.1202038 · DOI · Paper page
  5. Mok, 1994, Gynecol. Oncol., 52, 247, 10.1006/gyno.1994.1040 · DOI · Paper page
  6. Fazili, 1999, Oncogene, 18, 3104, 10.1038/sj.onc.1202649 · DOI · Paper page
  7. Tseng, 1999, J. Biol. Chem., 274, 31981, 10.1074/jbc.274.45.31981 · DOI
  8. Lowenstein, 1992, Cell, 70, 432
  9. Margolis, 1994, Prog. Biophys. Mol. Biol., 62, 223, 10.1016/0079-6107(94)90013-2 · DOI
  10. Tsoulfas, 1993, Neuron, 10, 975, 10.1016/0896-6273(93)90212-A · DOI
  11. Cobb, 1999, Prog. Biophys. Mol. Biol., 71, 479, 10.1016/S0079-6107(98)00056-X · DOI
  12. Robbins, 1992, Proc. Natl. Acad. Sci. U. S. A., 89, 6924, 10.1073/pnas.89.15.6924 · DOI
  13. Gutacker, 1999, Biochem. J., 339, 759, 10.1042/bj3390759 · DOI
  14. Karin, 1995, J. Biol. Chem., 270, 16483, 10.1074/jbc.270.28.16483 · DOI
  15. Xu, 1998, Oncogene, 16, 1561, 10.1038/sj.onc.1201678 · DOI
  16. Howell, 1997, EMBO J., 16, 121, 10.1093/emboj/16.1.121 · DOI · Paper page
  17. Howell, 1997, Nature, 389, 733, 10.1038/39607 · DOI · Paper page
  18. Marshall, 1995, Cell, 80, 179, 10.1016/0092-8674(95)90401-8 · DOI · Paper page
  19. York, 1998, Nature, 392, 622, 10.1038/33451 · DOI
  20. Khazaie, 1993, Cancer Metastasis Rev., 12, 255, 10.1007/BF00665957 · DOI
  21. Ware, 1998, Cancer Metastasis Rev., 17, 443, 10.1023/A:1006114527274 · DOI
  22. Robinson, 1998, Curr. Biol., 8, 1141, 10.1016/S0960-9822(07)00485-X · DOI
  23. McCarty, 1998, Med. Hypotheses, 50, 511, 10.1016/S0306-9877(98)90273-0 · DOI
  24. Xu, 1995, J. Biol. Chem., 270, 14184, 10.1074/jbc.270.23.14184 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Zhou, J., & Hsieh, J.-T.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2001-07
Volume
276
Issue
30
Pages
27793-27798
ISSN
0021-9258
DOI
10.1074/jbc.m102803200
Cited by
97
References
0
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review